15902
19712
Nippon India Pharma Fund - Direct (G)
18.93
12.40
13.79
-1.53
0.25
7.41
12.50
17.61
https://storage.googleapis.com/5paisa-prod-storage/files/2024-06/nippon-india-mf_0.png
7
1.91
13.79
Nippon India Pharma Fund - Direct (G)
1.91
13.79
1.19
3.5
5 Years
Nippon India Pharma Fund - Direct (G)
-
NAV
643.59
07 Sep 2026
-
0.24%
1 Day
-
18.93%
3Y CAGR returns
-
₹ 100
Min SIP -
₹ 5000
Min Lumpsum -
0.99%
Expense Ratio -
9,279 Cr
Fund Size -
13 Years
Fund Age
SIP Calculator
₹
₹
Yr
- Invested Amount
- ₹ 00
- Wealth Gained
- ₹ 00
- Expected Amount
- ₹ 00
₹
Yr
- Invested Amount
- ₹ 00
- Wealth Gained
- ₹ 00
- Expected Amount
- ₹ 00
Returns and Ranks ( as on 07 Sep 2026 )
- 1Y Returns
- 3Y Returns
- 5Y Returns
- MAX Returns
- Trailing Returns
- 12.40%
- 18.93%
- 13.79%
- 17.61
- 13.17Alpha
- 4.26SD
- 0.67Beta
- 0.95Sharpe
- Exit Load
- 1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
- Tax implication
- Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Low
Low to
moderate Moderate Moderately
High High Very
High
moderate Moderate Moderately
High High Very
High
- Fund Name
-
- Equity
- Sectoral Fund
- Fund Size (Cr.) - ₹ 1,444
-
- Equity
- Sectoral Fund
- Fund Size (Cr.) - ₹ 5,400
-
- Equity
- Sectoral Fund
- Fund Size (Cr.) - ₹ 9,279
-
- Equity
- Sectoral Fund
- Fund Size (Cr.) - ₹ 437
-
- Equity
- Sectoral Fund
- Fund Size (Cr.) - ₹ 1,452
19712
- Fund Name
-
- Equity
- Thematic Fund
- AUM - ₹ 947
-
- Other
- FoFs Domestic
- AUM - ₹ 4,166
-
- Other
- FoFs Domestic
- AUM - ₹ 6,959
-
- Equity
- Thematic Fund
- AUM - ₹ 341
-
- Hybrid
- Multi Asset Allocation Fund
- AUM - ₹ 16,926
- Address :
- 4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
-
- Contact :
- +91022-68087000/1860260111
-
- Email ID :
- customercare@nipponindiaim.in
Mutual Fund by Category
Large Cap
- Fund Name
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 1,931
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 1,260
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 223
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 3,591
-
- Equity
- Large Cap Mutual Funds
- Fund Size (Cr.) - 2,145
Mid Cap
Multi Cap
ELSS
Focused
Sectoral / Thematic
Small Cap
Dividend Yield
Ultra Short Duration
Liquid Mutual
Gilt Mutual
Long Duration
Overnight Mutual
Floater Mutual
Arbitrage Mutual
Equity Savings Mutual
Aggressive Hybrid Mutual
Other Calculators
Frequently Asked Questions
Nippon India Pharma Fund - Direct (G) has delivered 18.85% since inception
The NAV of Nippon India Pharma Fund - Direct (G) is ₹511.22 as of 07 Sep 2026
The expense ratio of Nippon India Pharma Fund - Direct (G) is 0.99 % as of 07 Sep 2026
The AUM of Nippon India Pharma Fund - Direct (G) 7160.93 CR as of 07 Sep 2026
The minimum SIP amount of Nippon India Pharma Fund - Direct (G) is 100
The top stock holdings of Nippon India Pharma Fund - Direct (G) are
- Sun Pharma.Inds. - 13.31%
- Lupin - 7.25%
- Divi's Lab. - 6.52%
- Cipla - 6.03%
- Apollo Hospitals - 5.30%
The top sectors Nippon India Pharma Fund - Direct (G) has invested in are
- Pharmaceuticals & Biotech - 77.63%
- Healthcare Services - 17.57%
- Retailing - 3.14%
- Debt - 1.79%
- Cash & Others - -0.13%







